Indirekte hemagglutionasjon (I.H.A.)
ELI.H.A Distoma
ELI.H.A Distoma enables the quantitative determination, by indirect hemagglutination, of serum antibodies present in patients suffering from distomiasis (Fasciola hepatica).
ELI.H.A Schistosoma
ELI.H.A Schistosoma enables the quantitative determination, by indirect hemagglutination, of serum antibodies from patients with bilharziosis caused by Schistosoma mansoni (intestinal form), Schistosoma hæmatobium (urinary form) and Schistosoma intercalatum (rectal form).
ELI.H.A Echinococcus
ELI.H.A Echinococcus enables the quantitative determination, by indirect hemagglutination, of serum antibodies present in patients suffering from hydatidosis (Echinococcus granulosus).
ELI.H.A Toxo
ELI.H.A Toxo enables the quantitative determination, by indirect hemagglutination, of serum antibodies (IgG and/or IgM) present in patients suffering from toxoplasmosis (Toxoplasma gondii).
ELI.H.A Amoeba
ELI.H.A Amoeba enables the quantitative determination, by indirect hemagglutination, of serum antibodies present in patients suffering from amoebiasis (Entamoeba histolytica).